HELEN VAFAIE: Open Payments
NPI 1003805458 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $114 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $253 |
| Teva Pharmaceuticals USA, Inc. | 4 | $112 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Alkermes, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
Products named: COBENFY, UZEDY, FANAPT, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
